August 14, 2015
Boehringer Ingelheim Pharmaceuticals Inc. and other drugmakers continued their push to dismiss six retailers' pay-for-delay lawsuits over the stroke drug Aggrenox, arguing a recent ruling in a similar case does nothing to bolster the retailers' case.